Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAdjunctive use of lithium carbonate for the management of neutropenia in clozapine-treated children
Human Psychopharmacology: Clinical and Experimental, 09/14/09
Mattai A et al. – The authors study bolsters support for the use of lithium in the management of neutropenia in children treated with clozapine. Although the coadministration of lithium and clozapine appears effective in the management of neutropenia, it is not without its risks and clinicians must be diligent in their joint use of these medications.
Related Articles
A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy
Journal of Psychiatry & Neuroscience, 11/11/09
Relevance Score: 89%
A retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine
Acta Psychiatrica Scandinavica, 10/15/09
Relevance Score: 88%
Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia
Schizophrenia Research, 11/17/09
Relevance Score: 84%
In vitro and in vivo evaluation of the inhibition potential of risperidone toward clozapine biotransformation
British Journal of Clinical Pharmacology, 11/05/09
Relevance Score: 82%
Olanzapine-Induced Clinical Seizure: A Case Report
Clinical Neuropharmacology, 10/13/09
Relevance Score: 80%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of Methylphenidate on Cerebral Glucose Metabolism in Patients With Impaired Consciousness After Acquired Brain Injury
Clinical Neuropharmacology, 12/05/09
Gabapentin Enacarbil in Restless Legs Syndrome: A Phase 2b, 2-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Clinical Neuropharmacology, 12/05/09
Inhibition of long-term potentiation by valproic acid through modulation of cyclic AMP
Epilepsia, 12/05/09
Sponsor
Article Search
Sponsor